Welcome to our dedicated page for Brightspring Health Services SEC filings (Ticker: BTSGU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Brightspring Health Services's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Brightspring Health Services's regulatory disclosures and financial reporting.
BrightSpring Health Services' major shareholder KKR Phoenix Aggregator L.P. has sold part of its stake through a large secondary offering. On March 2, 2026, selling stockholders agreed to sell 20,000,000 shares of common stock, including 19,715,000 shares from KKR Phoenix Aggregator L.P., to an underwriter at a net price of $40.961 per share, with the deal closing on March 4, 2026. After the transaction, KKR Phoenix Aggregator L.P. directly holds 41,824,259 shares, and KKR-affiliated entities and founders Henry R. Kravis and George R. Roberts may be deemed to beneficially own up to 41,938,202 shares, representing about 21.8% of BrightSpring’s 192,369,354 shares outstanding as of the offering’s closing. KKR Phoenix Aggregator L.P. entered a lock-up agreement restricting most additional sales of BrightSpring stock for 60 days from March 2, 2026, unless the underwriter consents.
BrightSpring Health Services entered an underwriting agreement for an underwritten secondary offering of 20,000,000 shares of common stock at $41.15 per share. All of these shares were sold by KKR and management selling stockholders, so BrightSpring itself did not receive the sale proceeds, other than cash from related stock option exercises.
As part of the same transaction, BrightSpring repurchased 1,464,807 shares of its common stock from the underwriter. The underwriter did not receive underwriting fees on the repurchased shares. The deal was conducted under an automatic shelf registration on Form S-3ASR, with customary representations, covenants, and indemnification provisions.
BrightSpring Health Services filed its annual report describing a nationwide platform delivering home and community-based pharmacy and provider services to complex Senior and Specialty patients. The company serves over 465,000 patients daily through about 10,500 clinical providers and pharmacists across all 50 states.
BrightSpring is reorganizing its portfolio by agreeing to divest its Community Living business for $835 million, treating it as discontinued operations and sharpening focus on home health, hospice, rehab, primary care, and integrated pharmacy. The report notes substantial indebtedness of approximately $2.6 billion and a highly competitive, heavily regulated reimbursement environment.
BrightSpring Health Services Chairman, President and Chief Executive Officer Jon B. Rousseau reported a tax-related share withholding. On January 25, 2026, BrightSpring withheld 49,304 shares of common stock at $39.64 per share to cover taxes on the vesting of 109,442 restricted stock units.
After this transaction, Rousseau directly owned 1,023,880 shares of BrightSpring common stock. He also had an indirect interest in 369,763 shares held by the Rousseau Family Trust, and he disclaims beneficial ownership of those indirect shares beyond his pecuniary interest.
BrightSpring Health Services, Inc.’s Chief Financial Officer, Jennifer A. Phipps, reported a routine tax-related share withholding. On January 25, 2026, 33,190 shares of common stock were withheld at a price of $39.64 per share in connection with restricted stock units vesting.
The footnote explains these shares were retained by the company to cover withholding taxes tied to the vesting of 77,012 restricted stock units, using the closing stock price on January 23, 2026 as the net settlement price. After this transaction, Phipps beneficially owned 196,840 shares of common stock directly.
BrightSpring Health Services officer reports tax-related share withholding. On January 25, 2026, officer Lisa A. Nalley had 20,556 shares of BrightSpring common stock withheld by the company to cover taxes tied to the vesting of 47,503 restricted stock units, using a net settlement price based on the January 23, 2026 closing stock price. After this transaction, she beneficially owned 110,594 shares of common stock directly.
BrightSpring Health Services officer reports tax withholding share transaction. President, Community Living Robert Allen Barnes reported that on January 25, 2026, 6,972 shares of BrightSpring common stock were withheld by the company at $39.64 per share to cover taxes on vesting equity.
The withholding related to the vesting of 15,540 restricted stock units, settled using the January 23, 2026 closing stock price. After this administrative transaction, Barnes directly held 32,297 shares of BrightSpring common stock.
BlackRock, Inc. has filed a Schedule 13G reporting a passive ownership stake in BrightSpring Health Services Inc. common stock. BlackRock reports beneficial ownership of 18,127,555 shares, representing 9.9% of the outstanding common stock. It has sole voting power over 17,963,774 shares and sole dispositive power over 18,127,555 shares, with no shared voting or dispositive power.
The filing notes that various underlying clients have rights to dividends or sale proceeds from these shares, but no single client holds more than five percent of BrightSpring’s total outstanding common shares. BlackRock certifies that the shares were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing control of the company.